Amaris Elliott Engel

October 07, 2014 | National Law Journal

The U.S. Court of Appeals for the Tenth Circuit has upheld a $1 billion antitrust class action judgment against Dow Chemical Co. involving a conspiracy to fix prices for polyurethane products.

By Amaris Elliott-Engel

2 minute read

October 03, 2014 | National Law Journal

The Food and Drug Administration has issued new final guidance for manufacturers of "custom devices." These devices do not have to comply with the same regulatory requirements for most medical devices because they are made for patients with rare medical conditions or to meet the special needs of physicians.

By Amaris Elliott-Engel

2 minute read

October 03, 2014 | National Law Journal

What if hackers caused medical devices to malfunction? Disrupted healthcare services? Accessed patient information or electronic health record data? Those are examples of potential digital security pitfalls for the healthcare industry that the Food and Drug Administration is concerned about tackling.

By Amaris Elliott-Engel

2 minute read

October 03, 2014 | National Law Journal

What if hackers caused medical devices to malfunction? Disrupted healthcare services? Accessed patient information or electronic health record data? Those are examples of potential digital security pitfalls for the healthcare industry that the U.S. Food and Drug Administration is concerned about tackling.

By Amaris Elliott-Engel

2 minute read

October 03, 2014 | National Law Journal

The judge considering whether to grant a new trial after a jury returned a $9 billion verdict in the first federal Actos bellwether trial recently had several questions for the lawyers.

By Amaris Elliott-Engel

3 minute read

October 03, 2014 | National Law Journal

A federal magistrate judge presiding over pretrial matters in the transvaginal mesh multidistrict litigations has sided with the plaintiffs in the latest discovery dispute with Boston Scientific Corporation.

By Amaris Elliott-Engel

2 minute read

October 03, 2014 | National Law Journal

Plaintiffs alleging their use of Zoloft caused birth defects in their children may have lost their battle to have their four causation experts found admissible. But they are trying again.

By Amaris Elliott-Engel

3 minute read

October 03, 2014 | National Law Journal

Plaintiffs who allege their use of Nexium caused osteoporosis, bone fractures and decrease in bone density have had their general causation expert rejected by a federal judge.

By Amaris Elliott-Engel

2 minute read

October 01, 2014 | National Law Journal

The U.S. Court of Appeals for the Seventh Circuit has ordered the recalculation of a paper manufacturer's liability for a “Superfund” pollution site at the Lower Fox River in Wisconsin.

By Amaris Elliott-Engel

2 minute read

October 01, 2014 | National Law Journal

The Arkansas Constitution will not support a taxpayer class action alleging that Takeda Pharmaceuticals USA, Inc. and Eli Lilly and Company caused millions of tax dollars to be spent on Actos even though the drug was allegedly overpriced and harmful, the Arkansas Supreme Court has ruled.

By Amaris Elliott-Engel

2 minute read